The comparison between golimumab 100mg and 50mg RA patients at the time of ultrasound examination
| Golimumab 100mg (n=15) | Golimumab 50mg (n=40) | P value | |
|---|---|---|---|
| Age (years old) | 60.3±12.2 | 65.6±12.0 | 0.161 |
| Disease duration (years) | 17.5±9.6 | 14.2±9.5 | 0.263 |
| Duration of golimumab use (years) | 1.8±0.9 | 2.1±1.5 | 0.542 |
| DAS28-CRP | 3.6±1.0 | 2.3±0.9 | <0.001 |
| SDAI | 14.0±6.9 | 5.7±5.0 | <0.001 |
| Total GSUS score | 16.9±12.6 | 14.8±12.7 | 0.572 |
| Total PDUS score | 11.3±9.07 | 6.5±6.0 | 0.076 |
| Maximum PDUS grade | 2.0±1.0 | 1.6±0.8 | 0.207 |